Novak D - Search Results

1

Novak D, Utikal J. Novak D, et al. Int J Mol Sci. 2022 Jun 8;23(12):6401. doi: 10.3390/ijms23126401. Int J Mol Sci. 2022. PMID: 35742846 Free PMC article.

2

Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.

Knappe N, Novak D, Weina K, Bernhardt M, Reith M, Larribere L, Hölzel M, Tüting T, Gebhardt C, Umansky V, Utikal J. Knappe N, et al. Among authors: novak d. Stem Cells. 2016 Apr;34(4):832-46. doi: 10.1002/stem.2284. Epub 2016 Jan 19. Stem Cells. 2016. PMID: 26753613

3

TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.

Weina K, Wu H, Knappe N, Orouji E, Novak D, Bernhardt M, Hüser L, Larribère L, Umansky V, Gebhardt C, Utikal J. Weina K, et al. Among authors: novak d. Pigment Cell Melanoma Res. 2016 Jul;29(4):453-8. doi: 10.1111/pcmr.12483. Pigment Cell Melanoma Res. 2016. PMID: 27105574

4

SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.

Hüser L, Sachindra S, Granados K, Federico A, Larribère L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Among authors: novak d. Int J Cancer. 2018 Dec 15;143(12):3131-3142. doi: 10.1002/ijc.31609. Epub 2018 Oct 16. Int J Cancer. 2018. PMID: 29905375 Free article.

5

Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.

Wu H, Larribère L, Sun Q, Novak D, Sachindra S, Granados K, Umansky V, Utikal J. Wu H, et al. Among authors: novak d. Int J Cancer. 2018 Dec 1;143(11):2962-2972. doi: 10.1002/ijc.31799. Epub 2018 Sep 29. Int J Cancer. 2018. PMID: 30110134 Free article.

6

Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.

Orouji E, Federico A, Larribère L, Novak D, Lipka DB, Assenov Y, Sachindra S, Hüser L, Granados K, Gebhardt C, Plass C, Umansky V, Utikal J. Orouji E, et al. Among authors: novak d. Int J Cancer. 2019 Dec 15;145(12):3462-3477. doi: 10.1002/ijc.32432. Epub 2019 Jun 9. Int J Cancer. 2019. PMID: 31131878 Free article.

7

Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.

Granados K, Poelchen J, Novak D, Utikal J. Granados K, et al. Among authors: novak d. Int J Mol Sci. 2020 Nov 5;21(21):8274. doi: 10.3390/ijms21218274. Int J Mol Sci. 2020. PMID: 33167306 Free PMC article. Review.

8

FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor.

Sun Q, Novak D, Hüser L, Poelchen J, Wu H, Granados K, Federico A, Liu K, Steinfass T, Vierthaler M, Umansky V, Utikal J. Sun Q, et al. Among authors: novak d. Int J Cancer. 2021 Aug 1;149(3):657-674. doi: 10.1002/ijc.33591. Epub 2021 May 6. Int J Cancer. 2021. PMID: 33837564 Free article.

9

From skin to other cell types of the body.

Novak D, Weina K, Utikal J. Novak D, et al. J Dtsch Dermatol Ges. 2014 Sep;12(9):789-92. doi: 10.1111/ddg.12403. Epub 2014 Aug 1. J Dtsch Dermatol Ges. 2014. PMID: 25087921 Free article. Review.

10

Function and significance of MicroRNAs in benign and malignant human stem cells.

Utikal J, Abba M, Novak D, Moniuszko M, Allgayer H. Utikal J, et al. Among authors: novak d. Semin Cancer Biol. 2015 Dec;35:200-11. doi: 10.1016/j.semcancer.2015.07.001. Epub 2015 Jul 17. Semin Cancer Biol. 2015. PMID: 26192966 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page